Levels of HbA1c decreased in 4 of the individual treatment groups , as follows : for the triple DMARD therapy + IM glucocorticoids treatment arm , -5.5 mmoles/mole ( -0.50 % ) ( P < 0.001 ) , for the triple DMARD therapy + oral glucocorticoids treatment arm , -3.7 mmoles/mole ( -0.34 % ) ( P < 0.001 ) , for the MTX treatment arm , -0.8 mmoles/mole ( -0.08 % ) ( P = 0.018 ) , and for the HCQ treatment arm , -2.0 mmoles/mole ( -0.19 % ) ( P = 0.175 ) .